Sarah Churton

Sarah is an International Tax Partner and leads the Life Sciences Tax team for KPMG in the UK.

Sarah has extensive tax experience in the life sciences sector advising UK and non-UK headquartered groups of varying sizes and stages of commercialisation on cross-border tax issues.

With over 20 years’ experience with EY and KPMG, Sarah specialises in guiding companies on cross-border tax issues such as IP centralisation and restructuring, the UK’s response to Base Erosion and Profit Shifting (BEPS), group reorganisations, intra-group financing and Brexit. She has advised companies from the largest global Pharma companies to smaller biotech companies that are pre-IPO.

Sarah has previously spent over two years based in New York, providing UK tax advice and insight to US-headquartered groups.

In addition, Sarah is currently leading KPMG’s response to the UK consultation on the taxation of intangibles.